midazolam and rg 12525

midazolam has been researched along with rg 12525 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fayer, JL; Kirkesseli, S; Luo, Y; Sidhu, R; Stevens, JC; Zannikos, PN	1

Trials

1 trial(s) available for midazolam and rg 12525

Article	Year
Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity. Journal of clinical pharmacology, 2001, Volume: 41, Issue:3 Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Glucuronides; Half-Life; Humans; In Vitro Techniques; Leukotriene Antagonists; Male; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Models, Biological; Protein Binding; Quinolines; Receptors, Cytoplasmic and Nuclear; Tetrazoles; Transcription Factors	2001

Article

Year

Lack of correlation between in vitro inhibition of CYP3A-mediated metabolism by a PPAR-gamma agonist and its effect on the clinical pharmacokinetics of midazolam, an in vivo probe of CYP3A activity.

Journal of clinical pharmacology, 2001, Volume: 41, Issue:3

Topics: Adolescent; Adult; Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Glucuronides; Half-Life; Humans; In Vitro Techniques; Leukotriene Antagonists; Male; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Models, Biological; Protein Binding; Quinolines; Receptors, Cytoplasmic and Nuclear; Tetrazoles; Transcription Factors

2001